Thrombosis Research
Stay current in the field of thrombosis, hemostasis, and vascular biology.
What's Thrombosis Research APK?
Thrombosis Research is a app for Android, It's developed by Elsevier Inc author.
First released on google play in 9 years ago and latest version released in 4 years ago.
This app has 0 download times on Google play
This product is an app in Medical category. More infomartion of Thrombosis Research on google play
Thrombosis Research
Now it’s easy to stay current in the field of thrombosis, hemostasis, and vascular biology. The Thrombosis Research app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap. Now available for android smartphones and tablets!
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, and supplementary content
• Stream multimedia for faster viewing or download for later
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
Journal Subscribers: Log in with the same username and password that grants you access to the full journal content on the Thrombosis Research website. These credentials will allow full access to all content on the app.
About Thrombosis Research
Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. Rapid communication and high visibility is facilitated by on-line submission, processing, and dissemination through Science Direct with powerful on-line links to other journals and sources.
Our privacy policy is here: http://www.elsevier.com/EULA_non-Apple_apps
Now it’s easy to stay current in the field of thrombosis, hemostasis, and vascular biology. The Thrombosis Research app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap. Now available for android smartphones and tablets!
• Stay ahead with alerts when new issues are available and read Articles in Press throughout the month
• Experience innovative digital content with the newly introduced Article enhancements; featuring AudioSlides, Virtual Microscope, 3D Radiological Viewer, 3D Neuroimaging Viewer, and more.
• Get access to the journal content on the app via your institution’s IP
• Enjoy Open Access and Open Archive Content without having to login
• Accessibility support to assist the visually impaired
• Interact with figures, tables, and supplementary content
• Stream multimedia for faster viewing or download for later
• Take notes, highlight articles and share via email and social media
• Personalize your experience with My Reading List and save articles for offline reading
Journal Subscribers: Log in with the same username and password that grants you access to the full journal content on the Thrombosis Research website. These credentials will allow full access to all content on the app.
About Thrombosis Research
Thrombosis Research is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. Rapid communication and high visibility is facilitated by on-line submission, processing, and dissemination through Science Direct with powerful on-line links to other journals and sources.
Our privacy policy is here: http://www.elsevier.com/EULA_non-Apple_apps
